Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Sep 07, 2021 8:45 AM - Sep 07, 2021 5:00 PM

(Singapore Standard Time)

DIA Asia 2021-The Evolution Of Clinical Trials And Regulatory Science In A Post-Pandemic Digital World In Asia

The timing is as per Singapore Time Zone

Session 1: MRCT during COVID and post COVID

Session Chair(s)

Jing Ping  Yeo, PhD

Jing Ping Yeo, PhD

Head - Transformation

George Clinical, Singapore

Jessica  Liu, MD

Jessica Liu, MD

VP, Head of Merges and Acquisition Management Department

Tigermed Consulting Co., Ltd, China

The COVID-19 pandemic has caused major disruptions to execution of clinical trials worldwide, impacting all stakeholders across the clinical research industry. The regulatory agencies, ethics committee, researchers and investigative sites have demonstrated flexibility and ingenuity in adopting new approaches in managing and mitigating the challenges presented by COVID-19. These new approaches include (i) organisational preparedness; (ii) virtual trial conduct or decentralised trials which utilise the remote technologies (econsent, recruitment, drug distribution, teleconsult, remote data collection); (iii) remote oversight (monitoring, audit) of clinical trials; (iv) innovative protocol redesign. The considerations in embarking these approaches will be reviewed, from sponsors, CROs, regulators and sites perspectives. As the COVID-19 pandemic subsides, the benefits to remote management will continue to grow its adoption into post-COVID clinical trial designs and conducts, eventually becoming the industry new normal.

Speaker(s)

Fabio  LaMola

Facilitation of Clinical Research Through Collaboration And Mitigating Gaps In Innovation: Fabio LaMola

Partner, Global Healthcare Co-Head

L.E.K Consulting , Singapore

Daniel  Millar, MBA

Paradigm of complex innovative Clinical Trial Design during and post COVID-19: Daniel Millar, MBA

Senior Director, Strategic Business Transformation

Johnson & Johnson, United States

Jing  Liu, MD

Industry practice using virtual clinical trials: Jing Liu, MD

Corporate VP, Regional Head, Medical Sciences, APAC

Parexel International Inc., Japan

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.